What goes down your toilet and drain can end up on farm fields across the United States. Biosolids, or sewage sludge, are the ...

Fertilizing tomatoes in greenhouses is crucial for achieving abundant yields. Learn essential nutrients and how to prepare ...

Jalen Green continues to showcase himself as one of the most explosive players in the NBA. Case in point, a highlight he had in the Houston Rockets' latest matchup against the Chicago Bulls on ...

All products featured on Architectural Digest are independently selected by our editors. However, when you buy something through our retail links, we may earn an affiliate commission. You may be ...

The duo launched on a SpaceX Falcon 9 rocket at 11:10 p.m. EST (0310 March 12 GMT). There was a glimmer in the air tonight at Vandenberg Space Force Base in California, and it wasn't only because ...

Missing injured guards Amen Thompson, Fred VanVleet and Reed Sheppard didn’t stop the shorthanded Houston Rockets from dominating the glass in a 97-84 win against the Orlando Magic on Monday ...

SAN DIEGO — SpaceX is planning to launch NASA’s SPHEREx Observatory and PUNCH satellites from Vandenberg Space Force Base on Tuesday, March 11. It is targeting Tuesday at 8:10 p.m. PT for ...

In a matchup of two of the NBA's top-four defenses by net rating, the Houston Rockets (39-25) will welcome the Orlando Magic (30-35) to Toyota Center on Monday night. For the Rockets, it's the second ...

Rocket Cos. is pushing deeper into the property market with a deal to buy Redfin Corp. that values the real estate listing site at $1.75 billion. The Detroit-based financial technology group will ...

Scrub Recap: SpaceX has stopped fueling and has not gone live. This means SpaceX is standing down from the launch tonight. SpaceX confirmed the launch was scrubbed due to high winds in the area.

Tonight is Game 2 of a five-game road trip for the Orlando Magic (30-35) as they take the court in Houston against the Rockets (39-25). Orlando currently sits in eighth place in the Eastern Conference ...

Amgen’s $400 million eczema drug candidate has recorded two more phase 3 victories. The data drops provide more evidence that the Kyowa Kirin-partnered rocatinlimab improves outcomes in atopic ...